Lupin Limited (LUPIN NSE) stock market data APIs
INR1885.4308
10.12(0.5%)
as of July 11, 2025
Try our APIs with
free plan!
Lupin Limited Financial Data Overview
Price chart is built with
Anychart
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Prev. Close
1885.4308
Open
1895.552
High
1911.2011
Low
1885.8403
52 wk Range
1766.05-2402.9
Market Cap
901 347 M
P/E Ratio
26.4032
Shares Outstanding
457 M
Revenue
227 079 M
EPS
16.87
Dividends (Yield)
0.0041
Beta
0.307
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Lupin Limited data using free add-ons & libraries
Get Lupin Limited Fundamental Data
Lupin Limited Fundamental data includes:
- Net Revenue: 227 079 M
- EBITDA: 54 967 M
- Earnings Per Share: 71
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-14
- EPS/Forecast: 16.47
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Lupin Limited News
New
Lupin Announces the Acquisition of Renascience in the United Kingdom
SLOUGH, England, April 02, 2025--(BUSINESS WIRE)--Lupin Healthcare (UK) Limited, the wholly owned subsidiary of global pharma major Lupin Limited (Lupin) announced today the acquisition of Renascience...
Lupin Ltd (BOM:500257) Q3 2025 Earnings Call Highlights: Record Margins and Strategic Growth ...
Revenue: Q3 FY25 sales at INR5,619 crores, up 10.6% year-on-year. EBITDA Margin: 24.3% for Q3 FY25, highest in five years. Gross Margin: 69.4% in Q3 FY25, up from 66% last year. India Business Growth:...
Lupin and Avas Launch NaMuscla® in Italy
Lupin Ltd Lupin and Avas Launch NaMuscla® in Italy Enables expanded access to the only EU-approved treatment for the myotonia symptoms in adults with non-dystrophic myotonic disorders Mumbai, Zu...
Lupin Ltd (BOM:500257) Q2 FY25 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Revenue: INR 5,497 crores for Q2 FY25, up 11.3% year-on-year. EBITDA: INR 1,308 crores, an increase of 42% year-on-year, with margins of 23.8%. Gross Margin: 69.3% in Q2 FY25, up from 65.5% in Q2 last...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
